查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2143381

基因融合檢測市場：依類別、技術、適應症、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Gene Fusion Testing Market, By Category, By Technology, By Indication, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 350 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，基因融合檢測市場價值將達到 8.301 億美元，從 2026 年到 2033 年將以 13.1% 的複合年成長率成長。

全球基因融合檢測市場是指分子診斷和精準醫療領域的一個分支，專門用於檢測在包括腫瘤在內的各種疾病發展過程中發生的基因突變，例如基因融合。基因易位檢測用於識別導致癌症發生的蛋白質突變。隨著對新技術的需求不斷成長，全球基因融合檢測市場已成為精準醫療領域的重要組成部分，能夠根據患者的遺傳背景制定個人化的治療方案。

全球基因融合檢測市場是實現基於基因異常資訊進行癌症個體化治療的關鍵領域。包括NGS（次世代定序）、FISH（螢光原位雜合反應）和PCR（聚合酵素鏈鎖反應）在內的多種技術被應用於全球基因融合檢測市場，用於檢測各種癌症中的基因轉位。這些技術提高了基因融合檢測的準確性，從而支持精準診斷和標靶癌症治療決策。

基因融合檢測市場—市場動態

癌症發生率的上升正在加速市場擴張。

癌症發生率的上升推動了基因融合檢測的需求。這是因為，隨著癌症患者數量的增加，人們越來越需要精準的分子檢測來識別可用於治療的突變，並制定個人化的治療方案。例如，根據歐盟統計局2026年3月的數據，癌症是歐盟第二大死因，約佔同期所有死亡人數的23.9%（116萬人）。癌症病例在老年人群中更為常見，65歲及以上人群的標準化死亡率為每10萬人936例，而65歲以下人群的標準化死亡率為每10萬人62.9例。歐盟整體的標準化癌症死亡率為每10萬人233.1例，但男性（每10萬人302.8例）和女性（每10萬人183.7例）的死亡率較高。預計這些趨勢將加速癌症診斷和治療方案製定中對基因融合檢測的需求。

基因融合檢測市場－市場區隔分析：

全球基因融合檢測市場按類別、技術、適應症、最終用戶和地區進行細分。

由於聚合酵素鏈鎖反應(PCR) 技術具有高靈敏度、快速出結果以及在癌症患者篩檢和分子譜分析中檢測基因融合的廣泛應用，因此在基因融合檢測市場中佔據重要地位。例如，2025 年 2 月，《PLOS ONE》期刊報道，高頻 PCR 檢測已應用於約 3,421 名醫護人員和 28.5 萬份口腔拭子檢體。由於德國養老院強制要求未接種疫苗的醫護人員以及所有醫護人員每週進行兩次 PCR 檢測，每月總合進行了 17940 次 PCR 檢測，其中 17479 次為已完成檢測。這些技術能夠可靠、有效率、快速地檢測具有臨床應用價值的基因融合事件。

基因融合檢測市場—區域分析

從區域數據來看，亞太地區預計將成為全球基因融合檢測市場成長最快的地區之一，這主要得益於診斷公司數量的增加以及對分子診斷領域的投資。例如，印度品牌股權基金會（IBEF）於2026年6月宣布，印度診斷設備市場規模將從2023年的40億美元成長至2027年的60億美元。市場需求顯著成長，為診斷設備製造商拓展在印度市場的佔有率提供了絕佳機會。此外，受醫療保健、醫院基礎設施和保險覆蓋範圍不斷擴大的推動，印度醫療設備市場預計將從2025年的152億美元成長至2030年的501億美元。這一趨勢可望提升全部區域的診斷能力，並加速基因融合檢測的普及應用。

新加坡基因融合檢測市場—國家概況

新加坡已建立起一套快速核准和監管伴隨診斷及分子診斷的流程，縮短了產品上市時間，並加速了創新成果的傳播。根據新加坡經濟發展局（政府機構）統計，截至2025年8月，新加坡總合及全球企業生態系統已涵蓋400多家公司，僱用員工超過17,000人。此外，全球領先的醫療技術公司中，排名前30的跨國公司均在新加坡開展業務。這些醫療技術公司每年生產價值超過190億新元的醫療設備，包括隱形眼鏡和心臟植入等。令人驚訝的是，這30家跨國公司中有超過20家已在新加坡設立了研發中心。

此外，新加坡的國家精準醫療舉措和SG100K計畫到2031年對約佔新加坡總人口10%的人口進行大規模資料點的詳細分析，包括生活方式、臨床因素、基因組資訊和環境因素，所有10萬新加坡人都將接受基因測序和分析。所有這些能力將推動先進診斷技術的發展，包括基於人工智慧的診斷技術（能夠更快、更準確地處理醫學影像）、癌症風險建模以及先天性聽力損失風險預測。

目錄

第1章：基因融合檢測市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：基因融合檢測的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：基因融合檢測產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：基因融合檢測市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：基因融合檢測市場現狀

  • 基因融合檢測市場佔有率分析（2025年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：基因融合檢測市場：依類別分類

  • 概述
    • 基於細分市場的市場佔有率分析：按類別
    • 診斷
    • 研究

第8章：基因融合檢測市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 免疫組織化學（IHC）
    • 聚合酵素鏈鎖反應（PCR）
    • 螢光原位雜合反應（FISH）
    • 次世代定序（NGS）

第9章：基因融合檢測市場：依適應症分類

  • 概述
    • 基於細分市場的市佔率分析：按適應症
    • 骨髓惡性腫瘤
    • 固體癌

第10章 基因融合檢測市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 學術和研究機構
    • 醫院/診斷檢查室
    • 製藥和生物技術公司
    • 其他

第11章 基因融合檢測市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：基因融合檢測產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Amoy Diagnostics Co., Ltd.
    • Arima Genomics, Inc.
    • Biocare Medical, LLC
    • Biocartis NV
    • Caris Life Sciences
    • Danaher Corporation
    • Empire Genomics, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Guardant Health, Inc.
    • Illumina, Inc.
    • Integrated DNA Technologies, Inc.（ArcherDX）
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • NeoGenomics, Inc.
    • OncoDNA SA
    • Paragon Genomics, Inc.
    • QIAGEN NV
    • Thermo Fisher Scientific Inc.
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7537

Gene Fusion Testing market size was valued at US$ 830.1 Million in 2025, expanding at a CAGR of 13.1% from 2026 to 2033.

The global Gene Fusion Testing market refers to that part of molecular diagnostics and precision medicine that was developed specifically for testing genetic mutations, including gene fusions, occurring during the process of various diseases' development, including oncology. A gene translocation test is used for identifying protein mutations that result in the development of cancer. As the demand for new technologies has been constantly rising, the global Gene Fusion Testing market has become an integral part of the field of precision medicine, allowing for creating a personalized approach to treating patients based on their genetic background.

The global Gene Fusion Testing market represents a key field for personalizing cancer therapy on the basis of information about genetic abnormalities. There are several technologies that are used in the global Gene Fusion Testing market for the purpose of detecting gene translocations in cases of different kinds of cancer, such as NGS (next generation sequencing), FISH (fluorescence in situ hybridization), and PCR (polymerase chain reaction). These technologies enhance gene fusion detection, supporting accurate diagnosis and targeted cancer treatment decision.

Gene Fusion Testing Market- Market Dynamics

Increasing Cancer Disease Prevalence to Accelerate Market Expansion

The increasing prevalence of cancer is driving demand for gene fusion testing because of the growing number of cancer patients, who increase the need for accurate molecular tests for actionable mutations and for treatment planning in each particular case. For example, in March 2026, according to Eurostat, cancer was the second most common cause of deaths in the EU, and there were about 1.16 million cases (23.9%) out of all deaths in this period. The cancer cases were more common among the elder population, as the standardized death rate was 936.0 cases per 100,000 inhabitants over 65 years of age, while the death rate among the younger population was 62.9 per 100,000 inhabitants under 65 years of age. There were 233.1 cases of cancer per 100,000 inhabitants in the total EU standardized death rate from cancer, while the death rate among males was 302.8 cases and among females was 183.7 cases per 100,000 inhabitants. These trends are expected to accelerate demand for gene fusion testing in cancer diagnosis and treatment planning.

Gene Fusion Testing Market- Segmentation Analysis:

The Global Gene Fusion Testing market is segmented on the basis of Category, Technology, Indication, End User, and Region.

Based on technology, Polymerase Chain Reaction (PCR) holds an important position in the Gene Fusion Testing market due to greater sensitivity and quick turnaround time as well as greater applications in the detection of gene fusions for screening and molecular profiling of cancer patients. For instance, in February 2025, according to a PLOS ONE (Org.), the high-frequency PCR testing method was used for about 3,421 healthcare workers and in around 285,000 oral swab samples. Unvaccinated healthcare workers were mandated to do PCR tests twice a week; all healthcare workers were mandated to do PCR tests twice a week, leading to a total of 17,940 PCR tests and 17,479 in a month at a German care facility conducting continuous surveillance of SARS-CoV-2. These technologies facilitate reliable, efficient, and quick detection of clinically actionable gene fusion events.

Gene Fusion Testing Market- Geographical Insights

Based on region, Asia-Pacific is projected to be the growing region in the global Gene Fusion Testing market due to the rising presence of diagnostic companies and investments in molecular diagnostics. For example, in June 2026, the India Brand Equity Foundation (IBEF) stated that India's market for diagnostic devices will achieve ($6,000 million) in 2027, as compared to or ($4,000 million) in CY23. There is significant growth in the demand, which offers an opportunity to diagnostic companies to increase their presence in the Indian region. Moreover, India's market for medical devices is forecasted to reach from ($15,200 million) in 2025 to ($50,100 million) in 2030 because of the growing demand for healthcare, hospital infrastructure, and insurance coverage. This trend is expected to strengthen diagnostic capabilities and accelerate gene fusion testing adoption across Asia-Pacific.

Singapore Gene Fusion Testing Market - Country Insights

Singapore is developing rapid routes towards approving and regulating companion and molecular diagnostics, and this ensures faster time-to-market and increased adoption of innovations. In August 2025, according to the Singapore Economic Development Board (Gov), Singapore's ecosystem of companies, either local or global, amounts to a total of more than 400 companies employing over 17,000 individuals, and the topmost MedTech companies of the world include the top 30 MNCs, which are operating in Singapore. These MedTech companies manufacture a total value of more than S$19 billion SGD of high-value medical devices per year, which includes, among others, contact lenses and cardiac implants, and one of the most amazing facts, which is indeed amazing, is that out of the total 30 MNCs, more than 20 companies set up R&D centres in Singapore.

And the nation's National Precision Medicine Initiative and SG100K Programme expect Singapore to conduct a detailed analysis of large data points like lifestyles, clinical factors, genomics, and environmental factors of around ten per cent of the total population of Singapore up to 2031, and all of the 100,000 Singaporeans will undergo genomic sequencing and analysis. All of these capabilities go on to facilitate the development of advanced diagnostic technologies, which include AI-based diagnostics that process medical images faster and more accurately, cancer-risk modelling, congenital hearing loss risk prediction, and others.

Gene Fusion Testing Market- Competitive Landscape:

Technological innovations, investments, and finance are key drivers that propel the worldwide Gene Fusion Testing market forward. There are some well-known companies like Roche, Guardant Health, Illumina, Biocartis, and Amoy Diagnostics that are contributing to technology development in order to drive the growth of the global market of gene fusion testing, along with the use of the above-mentioned technology to conduct gene fusion testing. In May 2026, Roche signed an agreement with PathAI, buying the company for $750 million in cash upfront and $300 million in milestones, and this will help Roche be a better competitor in the industry of digital pathology and companion diagnostics using artificial intelligence. These strategic developments are expected to accelerate innovation and expand gene fusion testing capabilities.

Recent Developments:

In July 2025, Amoy Diagnostics, Riken Genesis, and Precision Medicine Asia have announced that the AmoyDx(R) Pan Lung Cancer PCR Panel is an approved companion diagnostic for amivantamab and lazertinib in Japan. It is a complete test kit for screening of mutations in various genes like EGFR, ALK, ROS1, KRAS, BRAF, HER2, RET, MET, NTRK1, NTRK2, and NTRK3, including ALK, ROS1, and RET gene fusions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE FUSION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amoy Diagnostics Co., Ltd.
  • Arima Genomics, Inc.
  • Biocare Medical, LLC
  • Biocartis NV
  • Caris Life Sciences
  • Danaher Corporation
  • Empire Genomics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. (ArcherDX)
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • NeoGenomics, Inc.
  • OncoDNA SA
  • Paragon Genomics, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL GENE FUSION TESTING MARKET, BY CATEGORY- MARKET ANALYSIS, 2020 - 2033

  • Diagnostic
  • Research

GLOBAL GENE FUSION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Immunohistochemistry (IHC)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In-Situ Hybridization (FISH)
  • Next-Generation Sequencing (NGS)

GLOBAL GENE FUSION TESTING MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033

  • Hematological Malignancies
  • Solid Tumors

GLOBAL GENE FUSION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Academic & Research Centers
  • Hospitals and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

GLOBAL GENE FUSION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Gene Fusion Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gene Fusion Testing Market Snippet by Category
    • 2.1.2. Gene Fusion Testing Market Snippet by Technology
    • 2.1.3. Gene Fusion Testing Market Snippet by Indication
    • 2.1.4. Gene Fusion Testing Market Snippet by End User
    • 2.1.5. Gene Fusion Testing Market Snippet by Country
    • 2.1.6. Gene Fusion Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Gene Fusion Testing Key Market Trends

  • 3.1. Gene Fusion Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gene Fusion Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gene Fusion Testing Market Opportunities
  • 3.4. Gene Fusion Testing Market Future Trends

4. Gene Fusion Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gene Fusion Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Gene Fusion Testing Market Landscape

  • 6.1. Gene Fusion Testing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gene Fusion Testing Market - By Category

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Category, 2025 & 2033 (%)
    • 7.1.2. Diagnostic
    • 7.1.3. Research

8. Gene Fusion Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 8.1.2. Immunohistochemistry (IHC)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Fluorescence In-Situ Hybridization (FISH)
    • 8.1.5. Next-Generation Sequencing (NGS)

9. Gene Fusion Testing Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
    • 9.1.2. Hematological Malignancies
    • 9.1.3. Solid Tumors

10. Gene Fusion Testing Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. Academic & Research Centers
    • 10.1.3. Hospitals and Diagnostic Laboratories
    • 10.1.4. Pharmaceutical and Biotechnology Companies
    • 10.1.5. Others

11. Gene Fusion Testing Market - By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Gene Fusion Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Gene Fusion Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Denmark Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Gene Fusion Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Gene Fusion Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Gene Fusion Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Gene Fusion Testing Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Amoy Diagnostics Co., Ltd.
    • 12.2.2. Arima Genomics, Inc.
    • 12.2.3. Biocare Medical, LLC
    • 12.2.4. Biocartis NV
    • 12.2.5. Caris Life Sciences
    • 12.2.6. Danaher Corporation
    • 12.2.7. Empire Genomics, Inc.
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Guardant Health, Inc.
    • 12.2.10. Illumina, Inc.
    • 12.2.11. Integrated DNA Technologies, Inc. (ArcherDX)
    • 12.2.12. Myriad Genetics, Inc.
    • 12.2.13. Natera, Inc.
    • 12.2.14. NeoGenomics, Inc.
    • 12.2.15. OncoDNA SA
    • 12.2.16. Paragon Genomics, Inc.
    • 12.2.17. QIAGEN N.V.
    • 12.2.18. Thermo Fisher Scientific Inc.
    • 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us